Related Experiment Video

Updated: Feb 15, 2026

Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function
05:03

Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function

Published on: December 11, 2019

9.1K

Transvenous pacing in pediatric patients with bipolar lumenless lead: Ten-year clinical experience

Paolo De Filippo1, Fabrizio Giofrè1, Cristina Leidi1

  • 1Cardiac Electrophysiology and Pacing Unit, Cardiovascular Department, Ospedale Papa Giovanni XXIII, Bergamo, Italy.

International Journal of Cardiology
|January 11, 2018
PubMed

Insights

The Select Secure™ lead demonstrated safe and effective performance in pediatric patients, including those with congenital heart disease. This study confirms its reliability for long-term cardiac device implantation in children.

Area of Science:

  • Pediatric Cardiology
  • Cardiac Electrophysiology
  • Medical Device Technology

Background:

  • Long-term performance of endocardial implanted systems in pediatric patients presents unique challenges.
  • The Select Secure™ lead is a potential solution for this patient population.
  • Evaluating lead performance in children with and without congenital heart disease is crucial.

Purpose of the Study:

  • To assess the long-term performance of the Select Secure™ lead in pediatric patients.
  • To analyze implantation success, complications, and electrical parameters.
  • To evaluate lead efficacy in children with and without congenital heart disease.

Main Methods:

  • Retrospective analysis of pediatric patients (<16 years) implanted with Select Secure™ leads (2006-2016).
  • Evaluation of clinical characteristics, electrical lead parameters, and complications.
  • Analysis included surgical revisions and other adverse events.

Main Results:

  • 40 pediatric patients received 57 Select Secure™ leads; 77.5% used axillary vein access.
  • Implantation was uneventful in all patients, with one lead dislodgement successfully managed.
  • Adequate pacing parameters were achieved during a mean follow-up of 6±2.9 years.

Conclusions:

  • The Select Secure™ lead, axillary vein access, intra-atrial loop, and sub-pectoral generator placement ensure safe pediatric implantation.
  • Effective cardiac stimulation was achieved at medium-term follow-up in this pediatric cohort.
  • This approach is suitable for pacemaker or ICD implantation in children.
Abstract

More Related Videos

Translational Rabbit Model of Chronic Cardiac Pacing06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

3.1K
Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults08:56

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Published on: November 7, 2014

14.4K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
281
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
318
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.0K
Bipolar Junction Transistor01:22

Bipolar Junction Transistor

Bipolar Junction Transistors (BJTs) are essential elements in electronic circuits, playing a crucial role in the functionality of amplifiers, memories, and microprocessors. These transistors can be designed as NPN or PNP based on their doping patterns. They consist of three layers: the emitter, base, and collector. The configuration of these layers and their respective doping levels—with N-type or P-type impurities—define the transistor's type and its operational...
1.6K